YUNET BAREA HERNANDEZ: Open Payments
NPI 1265287981 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,986 in 200 payments from 27 companies in 2025. Trend: 2023 $0 · 2024 $2,541 · 2025 $3,986
Food & beverage: $3,887Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $982 |
| Janssen Biotech, Inc. | 27 | $790 |
| Ardelyx, Inc. | 14 | $285 |
| PFIZER INC. | 16 | $270 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $265 |
| Gilead Sciences, Inc. | 9 | $188 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $176 |
| QOL Medical, LLC | 6 | $162 |
| Phathom Pharmaceuticals, Inc. | 12 | $153 |
| Madrigal Pharmaceuticals | 5 | $145 |
Products named: TREMFYA, RINVOQ, IBSRELA, LINZESS, XIFAXAN, Sucraid, ENTYVIO, XELJANZ.
Industry payments across KY — which companies pay providers there.
